SPRAVATO® PATIENT DRIVER / TRANSPORTATION FORM
Driver Information
Transportation Confirmation
I understand that the patient is receiving SPRAVATO® (esketamine) and may experience
sedation, dizziness, impaired attention, judgment, coordination, or other effects
following treatment.
I confirm that I will:
- Transport the patient directly from the treatment facility after the clinic confirms
discharge.
- Remain available to assist the patient with transportation after treatment.
- Not allow the patient to drive themselves home following treatment.
- Not allow the patient to operate machinery or engage in activities requiring full
alertness following treatment.
- Notify the clinic staff if I have concerns about the patient's condition or ability
to travel safely.
Patient Acknowledgment
I understand that I must arrange transportation with a responsible driver following each
SPRAVATO® treatment. I understand that I am not permitted to drive myself
home after treatment, even if I feel well enough to drive.